Skip to main content
logo
Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
3.810
+0.160 (4.38%)
At close: Jan 22, 2026, 4:00 PM EST
3.800
-0.010 (-0.26%)
Pre-market: Jan 23, 2026, 6:42 AM EST

Cellectar Biosciences Market Cap

Cellectar Biosciences has a market cap or net worth of $16.15 million as of January 23, 2026. Its market cap has increased by 12.19% in one year.

Market Cap
16.15M
Enterprise Value
4.03M
1-Year Change
12.19%
Ranking
#5019
Category
Nano-Cap
Stock Price
$3.81

Market Cap Chart

Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $16.15M, an increase of 115.40%. That is a compound annual growth rate of 3.87%.

History

DateMarket Cap% Change
Jan 22, 202616.20M29.60%
Dec 31, 202512.50M1.63%
Dec 31, 202412.30M-63.82%
Dec 29, 202334.00M112.50%
Dec 30, 202216.00M-60.59%
Dec 31, 202140.60M-27.24%
Dec 31, 202055.80M164.45%
Dec 31, 201921.10M185.14%
Dec 31, 20187.40M-65.90%
Dec 29, 201721.70M233.85%
Dec 30, 20166.50M3.17%
Dec 31, 20156.30M-73.08%
Dec 31, 201423.40M9.86%
Dec 31, 201321.30M-37.72%
Dec 31, 201234.20M187.39%
Dec 30, 201111.90M325.00%
Dec 31, 20102.80M-98.80%
Dec 31, 2009233.20M2,164.08%
Dec 31, 200810.30M-56.90%
Dec 31, 200723.90M-22.90%
Dec 29, 200631.00M-30.49%
Dec 30, 200544.60M494.67%
Nov 10, 20057.50M-
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Cadrenal Therapeutics17.86M
Citius Pharmaceuticals17.64M
KALA BIO16.67M
Hoth Therapeutics16.29M
Kairos Pharma16.24M
Applied Therapeutics16.16M
Tempest Therapeutics15.13M
Moleculin Biotech14.69M
Market Cap Rankings